Logo
Strongbridge Biopharma plc
biotechnology
Phone
(610) 254-9200
Employees
86
Headquarters
900 Northbrook Dr, Feasterville-Trevose, Pennsylvania, United States, 19053
Headquarters
900 Northbrook Dr, Feasterville-Trevose, Pennsylvania, United States, 19053
rare disease, neuromuscular, and endocrine, biotechnology, pharmaceutical, health care, medical, health, wellness & fitness
About Strongbridge Biopharma plc

Strongbridge Biopharma plc is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. We are called Stro...
Strongbridge Biopharma plc is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. We are called Strongbridge for a reason. Our name reflects the collective strength of our rare disease expertise, our product portfolio and pipeline, and our patient-driven culture—one that is fueled by performance, precision and heart. Together, we are working to remove the barriers and isolation associated with rare neuromuscular and endocrine diseases in order to connect patients with the life-enhancing treatment options they deserve. Strongbridge is incorporated in Ireland, and its U.S. headquarters are located just outside of Philadelphia, PA. Strongbridge Biopharma is publicly traded on the NASDAQ Global Market under the ticker symbol SBBP.\\Rare Focus. Rare Commitment. Rare Passion. That's Strongbridge. ----- Strongbridge Biopharma’s primary focus has been to build its franchise around rare endocrine disorders, which includes product candidates for the treatment of endogenous Cushing’s syndrome and acromegaly, two rare diseases with a high unmet need for innovative treatment options. Given the well-identified and concentrated prescriber base addressing its target markets, the Company intends to use a small, focused sales force to market its products, if approved, in the United States, European Union and other key global markets. The Company intends to identify and in-license or acquire products or product candidates that would be complementary to its existing rare endocrine franchise or that would form the basis for new rare disease franchises.
Compay BGContact Information
Join Apollo to reach decision makers at Strongbridge Biopharma plc
Contacts at Strongbridge Biopharma plc

Sr. Global Study Manager
Area Business Specialist
Chief Financial Officer
Sr. Study Leader (consultant)
Senior Vice President of Sales, Marketing and Commercial Operations
Area Business Manager
Chief Medical Officer
Vice President, Patient Solutions & Channel Operations
Director, Quality Assurance
Rare Disease Account Manager
Notable Alumni

Sales Assistant - Høyer

Rare Disease Specialist - Amicus Therapeutics

Medical Director Clinical Development (external) - Debiopharm

Professional Basketball Player -

Regional Medical Director - Santhera Pharmaceuticals

Oncology Rare Disease Specialist - Innate Pharma

Business Development Representative - Four Winds Interactive

Client Relations Analyst - 1SEO Digital Agency

Technologies Used

Cloudflare DNS
Domain Name Services
Outlook
Email Providers
CloudFlare Hosting
Hosting
Apache
Load Balancers
Adobe Tag Management
Tag Management
Nginx
Load Balancers
Browse Apollo's Directories

Company Search

Company Directory Search

People Search

People Directory Search

Find Verified Emails in Seconds

Use Apollo to easily get in touch with anyone in the world